Gemcitabine plus nab-paclitaxel or gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: A population-based, multicenter AGEO study

被引：1
|
作者：
Zaibet, S. [1 ]
Hautefeuille, V. [2 ]
Auclin, E. [1 ]
Lievre, A. [3 ]
Tougeron, D. [4 ,5 ]
Sarabi, M. [6 ]
Gilabert, M. [7 ]
Wasselin, J.
Edeline, J. [8 ]
Artru, P. [9 ]
Bechade, D. [10 ]
Morin, C. [6 ]
Taieb, J. [11 ]
Pernot, S. [10 ]
机构：
[1] AP HP, Paris, France
[2] CHU Amiens, Amiens, France
[3] CHU Rennes, Rennes, France
[4] Univ Poitiers Hosp, Gastroenterol Dept, Poitiers, France
[5] Univ Poitiers, Poitiers, France
[6] Ctr Leon Berard, Lyon, France
[7] Inst Paoli Calmettes, Marseille, France
[8] Ctr Eugene Marquis, Rennes, France
[9] Hop Prive Jean Mermoz, Lyon, France
[10] Inst Bergonie, Bordeaux, France
[11] Paris Descartes Univ, Georges Pompidou European Hosp, Sorbonne Paris Cite, Paris, France
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.04.462
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD-6
引用
收藏
页码：S213 / S214
页数：2
相关论文
共 50 条
  • [21] Second-line treatment of modified FOLFIRINOX or nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma
    Ozaka, Masato
    Sasaki, Takashi
    Yamada, Ikuhiro
    Kanata, Ryo
    Akiyama, Dai
    Katagiri, Tomoko
    Takano, Koichi
    Matsuyama, Masato
    Sasahira, Naoki
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [22] Successful Treatment with Nab-Paclitaxel and Gemcitabine after FOLFIRINOX Failure in a Patient with Metastasized Pancreatic Adenocarcinoma
    Berger, Anne K.
    Weber, Tim F.
    Jaeger, Dirk
    Springfeld, Christoph
    ONKOLOGIE, 2013, 36 (12): : 763 - 765
  • [23] Could the combination of Nab-paclitaxel plus gemcitabine salvage metastatic pancreatic adenocarcinoma after folfirinox failure? A single institutional retrospective analysis
    El Rassy, Elie
    Assi, Tarek
    El Karak, Fadi
    Ghosn, Marwan
    Kattan, Joseph
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2017, 41 (02) : E26 - E28
  • [24] Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Adenocarcinoma
    Grierson, Patrick M.
    Tan, Benjamin
    Pedersen, Katrina S.
    Park, Haeseong
    Suresh, Rama
    Amin, Manik A.
    Trikalinos, Nikolaos A.
    Knoerzer, Deborah
    Kreider, Brent
    Reddy, Anupama
    Liu, Jingxia
    Der, Channing J.
    Wang-Gillam, Andrea
    Lim, Kian-Huat
    ONCOLOGIST, 2023, 28 (02): : E115 - E123
  • [25] Nab-paclitaxel and gemcitabine plus camrelizumab and radiotherapy versus nab-paclitaxel and gemcitabine alone for locally advanced pancreatic adenocarcinoma: a prospective cohort study
    Shuling Chen
    Jiaxin Li
    Aoran Dong
    Zelong Liu
    Meiyan Zhu
    Meng Jin
    Guangyan Wei
    Shuang Wu
    Yan Wang
    Yong Chen
    Zhenwei Peng
    Journal of Hematology & Oncology, 16
  • [26] Nab-paclitaxel and gemcitabine plus camrelizumab and radiotherapy versus nab-paclitaxel and gemcitabine alone for locally advanced pancreatic adenocarcinoma: a prospective cohort study
    Chen, Shuling
    Li, Jiaxin
    Dong, Aoran
    Liu, Zelong
    Zhu, Meiyan
    Jin, Meng
    Wei, Guangyan
    Wu, Shuang
    Wang, Yan
    Chen, Yong
    Peng, Zhenwei
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
  • [27] Survival outcomes based on sequence of therapy using FOLFIRINOX and nab-paclitaxel plus gemcitabine in metastatic pancreatic ductal adenocarcinoma
    Baron, Kelsey
    Nevala-Plagemann, Christopher Duane
    Moser, Justin
    Haaland, Benjamin
    Wang, Xuechen
    Garrido-Laguna, Ignacio
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [28] Survival Outcomes Based on Sequence of Therapy Using FOLFIRINOX and Nab-Paclitaxel plus Gemcitabine in Metastatic Pancreatic Ductal Adenocarcinoma
    Baron, Margaret Kelsey
    Wang, Xuechen
    Nevala-Plagemann, Christopher
    Moser, Justin C.
    Haaland, Benjamin
    Garrido-Laguna, Ignacio
    PANCREAS, 2021, 50 (06) : 796 - 802
  • [29] Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter study
    Pointet, Anne-Laure
    Tougeron, David
    Pernot, Simon
    Pozet, Astrid
    Bechade, Dominique
    Trouilloud, Isabelle
    Lourenco, Nelson
    Hautefeuille, Vincent
    Locher, Christophe
    Williet, Nicolas
    Desrame, Jerome
    Artru, Pascal
    Soularue, Emilie
    Le Roy, Bertrand
    Taieb, Julien
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2020, 44 (03) : 295 - 301
  • [30] Gabrinox: A phase I-II of nab-paclitaxel plus gemcitabine followed by folfirinox in metastatic pancreatic adenocarcinoma
    Assenat, E.
    de la Fouchardiere, C.
    Mollevi, C.
    Samalin, E.
    Portales, F.
    Desseigne, F.
    Carenco, C.
    Dupuy, M.
    Lopez-Martinez, E.
    Fiess, C.
    Mazard, T.
    Ychou, M.
    ANNALS OF ONCOLOGY, 2016, 27
12345